According to our systematic review, there were 5 aberrantly methylated genes (including CDKN2A, MGMT, CDH13, RUNX3 and APC) associated with the pathological types of NSCLC, and the remaining 11 gene methylation events showed no significant difference between AC and SCC. This evidence concerns the gene RUNX3 and non-small cell lung carcinoma.